Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer? Article

Calonge, Ned, Klein, Roger D, Berg, Jonathan S et al. (2016). Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer? . GENETICS IN MEDICINE, 18(8), 770-779. 10.1038/gim.2015.173

Open Access

cited authors

  • Calonge, Ned; Klein, Roger D; Berg, Jonathan S; Campos-Outcalt, Doug; Djulbegovic, Benjamin; Ganiats, Theodore G; Janssens, A Cecile JW; Offit, Kenneth; Pauker, Stephen G; Richards, Carolyn Sue; Strickland, Ora L; Tunis, Sean; Williams, Marc S; Zallen, Doris T

sustainable development goals

authors

publication date

  • August 1, 2016

webpage

published in

keywords

  • 21-GENE RECURRENCE SCORE
  • 21-gene
  • ADJUVANT CHEMOTHERAPY
  • ASSAY
  • DISTANT RECURRENCE
  • Genetics & Heredity
  • HIGHLIGHTS
  • INTERNATIONAL EXPERT CONSENSUS
  • Life Sciences & Biomedicine
  • Oncotype
  • PRIMARY THERAPY
  • RISK
  • Science & Technology
  • TAMOXIFEN
  • WOMEN
  • breast cancer
  • gene expression profile
  • recurrence
  • tumor gene expression

Digital Object Identifier (DOI)

publisher

  • NATURE PUBLISHING GROUP

start page

  • 770

end page

  • 779

volume

  • 18

issue

  • 8